KOSPI · Healthcare · ₩349B
₩36,250+1.12%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 3.7% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기 동아에스티는 도입 신약이 회사 전체를 끌고 가는 분기였어요.”
In the company's words · 2026 1분기 filing